Sandu Pharmaceuticals informs about issuance of duplicate share certificate

25 May 2021 Evaluate

Pursuant to the regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, Sandu Pharmaceuticals has informed about the notice that Linkintime India, the Registrar and Share Transfer Agent (RTA) of the Company has stopped Transfer on receipt of the request for Duplicate issue of Shares from the Shareholder, Yogesh Date (Folio No: Y02059). Further details regarding the same as enclosed.

The above information is a part of company’s filings submitted to BSE.

Sandu Pharmaceutical Share Price

39.50 -0.70 (-1.74%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×